Foreign Investment Restrictions in Indonesia’s Pharmaceutical Sector: What Investors Must Know
The call came at 7 PM on a Friday. Our client’s planned pharma investment in Indonesia was in Jeopardy. They had just…
Trường (David) Lăng, as Founder and CEO of Viettonkin, dedicates his extensive expertise to fostering robust trade and investment bridges between Southeast Asia and global partners. With over 17 years of experience, he has successfully guided over 3,000 FDI projects and advised Fortune Global 500 corporations on complex market entry and expansion strategies. His impactful work includes providing technical assistance to governments, developing innovative initiatives like Viettonkin's 'FDI Desks,' and maintaining strategic relationships with central authorities and NGOs. David's thought leadership in economic development and policy advocacy empowers businesses worldwide to confidently navigate and thrive in emerging markets.
278 articles
The call came at 7 PM on a Friday. Our client’s planned pharma investment in Indonesia was in Jeopardy. They had just…
Three months into a planned market entry, a client’s health supplement registration was rejected. It wasn’t an issue with labeling or a…
The call came at 7 PM on a Friday. A new foreign investor, ready to launch a high-end wellness industry brand, was…
Vietnam’s pharmaceutical industry and healthcare sectors are no longer just growing; they are consolidating. In recent years, mergers and acquisitions (M&A) have…
The call came at 7 PM on a Friday. Our client’s multi-million-dollar acquisition in Indonesia, a key part of their strategy for…
Recent shifts in Vietnam’s regulatory landscape signal a deliberate move towards international standards in pharmacy practice, presenting both a complex challenge and…
The labyrinthine nature of Indonesian regulations often presents a deceptively straightforward facade, a lesson hard-learned through extensive on-the-ground experience. A client, a…
Belgium is home to sophisticated financial advisory capabilities, delivering services such as corporate finance, M&A, and restructuring to exacting EU standards. This…
Vietnam’s pharmaceutical industry is entering a historic growth phase, aiming for a market size of USD 20 billion by 2026, yet it…
Vietnam’s oil and gas transformation is accelerating, from refinery upgrades to offshore oil and gas exploration, creating a once-in-a-decade opening for advanced…
Talk to an ASEAN expert who has guided 2,000+ companies into the region.